Send us Feedback

Amylin Pharmaceuticals (AMLN)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
 
 
 
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Income Statement    (USD)
Annual | Quarterly
QUARTER ENDING 30-JUN
2011		 30-SEP
2011		 31-DEC
2011		 31-MAR
2012		 30-JUN
2012
Total Revenue 158M 175M 165M 154M 169M
Cost of Revenue 11.8M 11.7M 12.3M 34.6M 14.9M
Gross Profit 146M 163M 153M 119M 154M
Research & Development 45.1M 46.6M 27.7M 51.2M 42.3M
SG&A 65.2M 122M 553M 110M 109M
Amortization & Deprec 0 0 0 15.6M 35.8M
Other Expenses 126K 2.50M -430M -3.68M -3.27M
Total Operating Expenses 110M 171M 151M 173M 183M
Operating Income 35.8M -7.78M 1.83M -54.3M -28.9M
Other Income -60.7M 0 -432M 0 -2.14M
EBIT -24.8M -7.78M -430M -54.3M -31.1M
Minority Interest 0 0 0 0 0
Interest Expense 6.57M 5.41M 31.7M 44.7M 43.1M
Income Before Taxes -31.4M -13.2M -461M -99.0M -74.2M
Income Taxes 0 0 0 0 0
Net Income from Continuing Ops -31.4M -13.2M -461M -99.0M -74.2M
Income - Discontinued Ops 0 0 0 0 0
Extraordinary Items 0 0 0 0 0
Effect of Accounting Changes 0 0 0 0 0
Other Items 0 0 0 0 0
Net Income -31.4M -13.2M -461M -99.0M -74.2M
Preferred Dividends 0 0 0 0 0
Net Income to Common -31.4M -13.2M -461M -99.0M -74.2M
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki